Year |
Citation |
Score |
2015 |
Kornacki JR, Stuparu AD, Mrksich M. Acetyltransferase p300/CBP associated Factor (PCAF) regulates crosstalk-dependent acetylation of histone H3 by distal site recognition. Acs Chemical Biology. 10: 157-64. PMID 25203060 DOI: 10.1021/Cb5004527 |
0.451 |
|
2015 |
Kornacki JR, Stuparu AD, Mrksich M. Acetyltransferase p300/CBP associated factor (PCAF) regulates crosstalk-dependent acetylation of histone H3 by distal site recognition Acs Chemical Biology. 10: 157-164. DOI: 10.1021/cb5004527 |
0.402 |
|
2013 |
Lin JY, Stuparu AD, Huntington MD, Mrksich M, Odom TW. Nanopatterned substrates increase surface sensitivity for real-time biosensing Journal of Physical Chemistry C. 117: 5286-5292. DOI: 10.1021/Jp401598A |
0.461 |
|
2012 |
Ban L, Pettit N, Li L, Stuparu AD, Cai L, Chen W, Guan W, Han W, Wang PG, Mrksich M. Discovery of glycosyltransferases using carbohydrate arrays and mass spectrometry Nature Chemical Biology. 8: 769-773. PMID 22820418 DOI: 10.1038/Nchembio.1022 |
0.416 |
|
2010 |
Gao H, Yang JC, Lin JY, Stuparu AD, Lee MH, Mrksich M, Odom TW. Using the angle-dependent resonances of molded plasmonic crystals to improve the sensitivities of biosensors. Nano Letters. 10: 2549-54. PMID 20509678 DOI: 10.1021/Nl101165R |
0.434 |
|
Low-probability matches (unlikely to be authored by this person) |
2008 |
McAlpine MC, Agnew HD, Rohde RD, Blanco M, Ahmad H, Stuparu AD, Goddard WA, Heath JR. Peptide-nanowire hybrid materials for selective sensing of small molecules. Journal of the American Chemical Society. 130: 9583-9. PMID 18576642 DOI: 10.1021/Ja802506D |
0.172 |
|
2020 |
Sun DL, Poddar S, Pan RD, Rosser EW, Abt ER, Van Valkenburgh J, Le TM, Lok V, Hernandez SP, Song J, Li J, Turlik A, Chen X, Cheng CA, Chen W, ... ... Stuparu AD, et al. Isoquinoline thiosemicarbazone displays potent anticancer activity with efficacy against aggressive leukemias. Rsc Medicinal Chemistry. 11: 392-410. PMID 33479645 DOI: 10.1039/c9md00594c |
0.153 |
|
2018 |
Lisova K, Sergeev M, Evans-Axelsson S, Stuparu AD, Beykan S, Collins J, Jones J, Lassmann M, Herrmann K, Perrin D, Lee JT, Slavik R, van Dam RM. Microscale radiosynthesis, preclinical imaging and dosimetry study of [F]AMBF-TATE: A potential PET tracer for clinical imaging of somatostatin receptors. Nuclear Medicine and Biology. 61: 36-44. PMID 29747035 DOI: 10.1016/j.nucmedbio.2018.04.001 |
0.11 |
|
2020 |
Stuparu AD, Capri JR, Meyer C, Le TM, Evans-Axelsson SL, Current K, Lennox M, Mona CE, Fendler WP, Calais J, Eiber M, Dahlbom M, Czernin J, Radu CG, Lückerath K, et al. Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 33277393 DOI: 10.2967/jnumed.120.256263 |
0.081 |
|
2023 |
Meyer C, Stuparu A, Lueckerath K, Calais J, Czernin J, Slavik R, Dahlbom M. Tandem Isotope Therapy with Ac- and Lu-PSMA-617 in a Murine Model of Prostate Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 64: 1772-1778. PMID 37797974 DOI: 10.2967/jnumed.123.265433 |
0.078 |
|
2022 |
Meyer C, Prasad V, Stuparu A, Kletting P, Glatting G, Miksch J, Solbach C, Lueckerath K, Nyiranshuti L, Zhu S, Czernin J, Beer AJ, Slavik R, Calais J, Dahlbom M. Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225. Ejnmmi Research. 12: 65. PMID 36182983 DOI: 10.1186/s13550-022-00935-6 |
0.063 |
|
2019 |
Waldmann CM, Stuparu AD, van Dam RM, Slavik R. The Search for an Alternative to [Ga]Ga-DOTA-TATE in Neuroendocrine Tumor Theranostics: Current State of F-labeled Somatostatin Analog Development. Theranostics. 9: 1336-1347. PMID 30867834 DOI: 10.7150/thno.31806 |
0.057 |
|
2018 |
Lückerath K, Wei L, Fendler WP, Evans-Axelsson S, Stuparu AD, Slavik R, Mona CE, Calais J, Rettig M, Reiter RE, Herrmann K, Radu CG, Czernin J, Eiber M. Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer. Ejnmmi Research. 8: 96. PMID 30374743 DOI: 10.1186/S13550-018-0451-Z |
0.043 |
|
2020 |
Current K, Meyer C, Magyar CE, Mona CE, Almajano J, Slavik R, Stuparu AD, Cheng C, Dawson DW, Radu CG, Czernin J, Lueckerath K. Investigating PSMA-targeted radioligand therapy efficacy as a function of cellular PSMA levels and intra-tumoral PSMA heterogeneity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31932492 DOI: 10.1158/1078-0432.Ccr-19-1485 |
0.037 |
|
2018 |
Lückerath K, Stuparu AD, Wei L, Kim W, Radu CG, Mona CE, Calais J, Rettig M, Reiter RE, Czernin J, Slavik R, Herrmann K, Eiber M, Fendler W. Detection threshold and reproducibility ofGa-PSMA11 PET/CT in a mouse model of prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29602819 DOI: 10.2967/Jnumed.118.207704 |
0.035 |
|
2020 |
Stuparu AD, Meyer CAL, Evans-Axelsson SL, Lückerath K, Wei LH, Kim W, Poddar S, Mona CE, Dahlbom M, Girgis MD, Radu CG, Czernin J, Slavik R. Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study. Theranostics. 10: 2612-2620. PMID 32194823 DOI: 10.7150/Thno.42228 |
0.032 |
|
2017 |
Fendler WP, Stuparu AD, Evans-Axelsson S, Lückerath K, Wei L, Kim W, Poddar S, Said J, Radu CG, Eiber M, Czernin J, Slavik R, Herrmann K. Establishing (177)Lu-PSMA-617 radioligand therapy in a syngeneic model of murine prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28546332 DOI: 10.2967/Jnumed.117.193359 |
0.027 |
|
Hide low-probability matches. |